Aurinia Pharmaceuticals, Inc. (AUPH)
15.92
-0.13
(-0.81%)
USD |
NASDAQ |
Apr 20, 11:29
Aurinia Pharmaceuticals SG&A Expense (Quarterly) : 29.26M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Xenon Pharmaceuticals, Inc. | 22.07M |
| Oncolytics Biotech, Inc. | 2.18M |
| Edesa Biotech, Inc. | 1.217M |
| Lexaria Bioscience Corp. | 0.00 |
| ProMIS Neurosciences, Inc. | 1.404M |